Both in Pharmaceuticals
Lexaria Bioscience vs Moleculin Biotech
Over the past year LEXX returned −78.5% and MBRX returned −96.3%; their daily moves had a correlation of -0.16.
LEXX −78.5% MBRX −96.3%Growth of $1, one year, split-adjusted
| Metric | LEXX | MBRX |
|---|---|---|
| Price | $3.22 | $9.27 |
| Market cap | $6.8M | $9.4M |
| Today | +10.27% | +30.77% |
| 1 month | −0.2% | −18.6% |
| 6 months | −75.7% | −81.9% |
| Year to date | −65.2% | −86.0% |
| 1 year | −76.9% | −96.2% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 35.0× | — |
| Net cash | $3.6M | $7.3M |
| Dividend yield | — | — |
| Volatility (60d) | 195.2% | 850.6% |
| Short % of float | 16.0% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).